The Middle East and Africa Carbohydrase Market size is estimated to reach USD 0.31 billion by 2032 from a market value of USD 0.19 billion in 2024 at a CAGR of 6.22%. The Carbohydrase market is showcasing significant potential over the mentioned forecast period. The market continues to build up momentum with the pharma sector registering rapid growth over recent years, leading to increased interest shown by companies in the market.
Carbohydrase is a kind of enzyme, with a large family of cellulase, amylase etc. Carbohydrase is an important raw material in various application in different industries like, food, beverages, animal feed, pharmaceuticals, leather, textile, and others. One of the major purpose of carbohydrase in these industries is to reduce the greenhouse gas emission and avoid wastage of other raw materials.
The pharmaceutical industry has been witnessing a significant growth lately, which has been a crucial factor in the favour of carbohydrase market. Other key factors, driving the market growth include emerging applications of carbohydrase, advancements in technology in enzyme engineering, increasing demand in Asia-Pacific.
On the other hand, the market has been facing some restraints as well. These include temperature and pH in alpha-amylase activity as well as high production costs. These factors have been holding the market back from reaching its full potential.
The major companies showing interest in the market lately, include Dyadic International, Inc., Amano Enzyme Inc., AB Enzymes Gmbh, Novozymes, Royal DSM, CHR. Hansen Holding A/S, Advanced Enzymes, Verenium, E.I. Dupont De Nemours & Co., Specialty Enzymes.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region